At Alkermes, Diversity, Inclusion & Belonging means actively fostering a culture in which all voices are respected and valued, where employees can show up to work as their authentic selves and feel accepted.
This year’s Alkermes Inspiration Grants® is now officially open for applications! We look forward to reviewing proposals for innovative nonprofit programs to address addiction, serious mental illness or cancer. Program details: https://bit.ly/3f1SC5a
Competitive Grants Program Application Period to Begin on May 20, 2021
DUBLIN, May 13, 2021 /3BL Media/ -- Alkermes plc (Nasdaq: ALKS) today announced that the company will begin accepting applications for its Alkermes Inspiration Grants® program beginning on May 20, 2021. Now in its fifth year, this competitive grants program will provide up to a total of $500,000 in grants to assist nonprofit organizations in their work to address the needs of people living with addiction, serious mental illness or cancer.
May is Mental Health Month! The COVID-19 pandemic has put mental health front and center. This month we encourage everyone to learn more, share resources, and consider how you can support those who are living with mental illness.
Two organizations with presence in the greater Boston area honored for their commitment to gender diversity in the workplace
BOSTON, May 12, 2021 /3BL Media/ - Alkermes plc and Blue Cross Blue Shield of Massachusetts are the recipients of The Boston Club’s first President’s Award, recognizing organizations that are leaders in supporting the advancement of women in the C-suite and boardroom, but whose corporate structure does not meet the specific research methodology used by the Club in its annual census of public companies.
New Outcomes Research in Patients With Schizophrenia or Bipolar I Disorder to be Presented
DUBLIN, May 4, 2021 /3BL Media/ -- Alkermes plc (Nasdaq: ALKS) recently announced plans to present clinical data and outcomes research from its psychiatry portfolio at three scientific conferences during Mental Health Awareness Month in May. The meetings, all held virtually, include:
Myrelationshipwithalcohol.com Provides Information About the Disease, Personal Stories and an Interactive Questionnaire to Assess Drinking Patterns
DUBLIN, April 29, 2021 /3BL Media/ -- Myrelationshipwithalcohol.com, a new website sponsored by Alkermes, Inc., a subsidiary of Alkermes plc (Nasdaq: ALKS), recently went live to offer education about alcohol
New Exploratory Analyses Presented From ENLIGHTEN-2 Study of LYBALVI™ in Patients With Schizophrenia
DUBLIN, April 22, 2021 /3BL Media/ -- Alkermes plc (Nasdaq: ALKS) recently announced the presentation of new research from its psychiatry portfolio at the 2021 Congress of the Schizophrenia International Research Society (SIRS), taking place virtually April 17-21, 2021.